Literature DB >> 18824172

The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning.

Michael P Flaherty1, Yiru Guo, Sumit Tiwari, Arash Rezazadeh, Greg Hunt, Santosh K Sanganalmath, Xian-Liang Tang, Roberto Bolli, Buddhadeb Dawn.   

Abstract

The specific role of TNF-alpha receptors I (TNFR-I, p55) and II (TNFR-II, p75) in myocardial ischemic injury remains unclear. Using genetically engineered mice, we examined the relative effects of TNF-alpha signaling via p55 and p75 in acute myocardial ischemia/reperfusion injury under basal conditions and in late preconditioning (PC). Wild-type (WT) (C57BL/6 and B6,129) mice and mice lacking TNF-alpha (TNF-alpha(-/-)), p55 (p55(-/-)), p75 (p75(-/-)), or both receptors (p55(-/-)/p75(-/-)) underwent 30 min of coronary occlusion and 24 h of reperfusion with or without six cycles of 4-min coronary occlusion/4-min reperfusion (O/R) 24 h earlier (ischemic PC). Six cycles of O/R reduced infarct size 24 h later in WT mice, indicating a late PC effect. This late PC-induced infarct-sparing effect was abolished not only in TNF-alpha(-/-) and p55(-/-)/p75(-/-) mice, but also in p55(-/-) and p75(-/-) mice, indicating that TNF-alpha signaling via both p55 and p75 is necessary for the development of protection. In nonpreconditioned TNF-alpha(-/-), p55(-/-)/p75(-/-), and p75(-/-) mice, infarct size was similar to strain-matched WT mice. In contrast, infarct size in nonpreconditioned p55(-/-) mice was reduced compared with nonpreconditioned WT mice. We conclude that (i) unopposed p75 signaling (in the absence of p55) reduces infarct size following acute ischemia/reperfusion injury in naive myocardium, whereas unopposed p55 signaling (in the absence of p75) has no effect; and (ii) the development of the infarct-sparing effects of the late phase of PC requires nonredundant signaling via both p55 and p75 receptors. These findings reveal a fundamental, heretofore unrecognized, difference between the two TNF-alpha receptors in the setting of myocardial ischemia/reperfusion injury: that is, both p55 and p75 are necessary for the development of protection during late PC, but only signaling via p75 is protective in nonpreconditioned myocardium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18824172      PMCID: PMC2645001          DOI: 10.1016/j.yjmcc.2008.08.014

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  33 in total

1.  Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction.

Authors:  Andreas Skyschally; Petra Gres; Simone Hoffmann; Michael Haude; Raimund Erbel; Rainer Schulz; Gerd Heusch
Journal:  Circ Res       Date:  2006-12-14       Impact factor: 17.367

2.  Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences.

Authors:  Qianhong Li; Yiru Guo; Wei Tan; Adam B Stein; Buddhadeb Dawn; Wen-Jian Wu; Xiaoping Zhu; Xiaoqin Lu; Xiaoming Xu; Tariq Siddiqui; Sumit Tiwari; Roberto Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-19       Impact factor: 4.733

3.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

4.  Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene.

Authors:  Robert M Smith; Naushaad Suleman; Joy McCarthy; Michael N Sack
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

5.  Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.

Authors:  Buddhadeb Dawn; Yiru Guo; Arash Rezazadeh; Ou-Li Wang; Adam B Stein; Greg Hunt; Jai Varma; Yu-Ting Xuan; Wen-Jian Wu; Wei Tan; Xiaoping Zhu; Roberto Bolli
Journal:  J Mol Cell Cardiol       Date:  2004-07       Impact factor: 5.000

6.  Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart.

Authors:  G Torre-Amione; S Kapadia; J Lee; J B Durand; R D Bies; J B Young; D L Mann
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

7.  Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling.

Authors:  Ravi Ramani; Michael Mathier; Ping Wang; Gregory Gibson; Sandra Tögel; Jennifer Dawson; Anthony Bauer; Sean Alber; Simon C Watkins; Charles F McTiernan; Arthur M Feldman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-09       Impact factor: 4.733

Review 8.  Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation.

Authors:  Hongxiu Li; Xin Lin
Journal:  Cytokine       Date:  2008-01       Impact factor: 3.861

9.  IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.

Authors:  Buddhadeb Dawn; Yu-Ting Xuan; Yiru Guo; Arash Rezazadeh; Adam B Stein; Greg Hunt; Wen-Jian Wu; Wei Tan; Roberto Bolli
Journal:  Cardiovasc Res       Date:  2004-10-01       Impact factor: 10.787

10.  Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

Authors:  Douglas L Mann; John J V McMurray; Milton Packer; Karl Swedberg; Jeffrey S Borer; Wilson S Colucci; Jacques Djian; Helmut Drexler; Arthur Feldman; Lars Kober; Henry Krum; Peter Liu; Markku Nieminen; Luigi Tavazzi; Dirk Jan van Veldhuisen; Anders Waldenstrom; Marshelle Warren; Arne Westheim; Faiez Zannad; Thomas Fleming
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

View more
  16 in total

1.  Disruption of group IVA cytosolic phospholipase A(2) attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathway.

Authors:  Yukio Saito; Kazuhiro Watanabe; Daisuke Fujioka; Takamitsu Nakamura; Jun-ei Obata; Kenichi Kawabata; Yosuke Watanabe; Hideto Mishina; Shun Tamaru; Yoshihiro Kita; Takao Shimizu; Kiyotaka Kugiyama
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

2.  Nox1 NADPH oxidase is necessary for late but not early myocardial ischaemic preconditioning.

Authors:  Shuxia Jiang; Jennifer Streeter; Brandon M Schickling; Kathy Zimmerman; Robert M Weiss; Francis J Miller
Journal:  Cardiovasc Res       Date:  2014-02-05       Impact factor: 10.787

Review 3.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

4.  In vivo systems analysis identifies spatial and temporal aspects of the modulation of TNF-α-induced apoptosis and proliferation by MAPKs.

Authors:  Ken S Lau; Alwin M Juchheim; Kimberly R Cavaliere; Sarah R Philips; Douglas A Lauffenburger; Kevin M Haigis
Journal:  Sci Signal       Date:  2011-03-22       Impact factor: 8.192

5.  Tumor necrosis factor-α signaling via TNFR1/p55 is deleterious whereas TNFR2/p75 signaling is protective in adult infarct myocardium.

Authors:  Raj Kishore; Tengiz Tkebuchava; Sharath P Sasi; Marcy Silver; Hu-Ya Gilbert; Young-Sup Yoon; Hee-Young Park; Tina Thorne; Douglas W Losordo; David A Goukassian
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

6.  MicroRNA-223-5p and -3p Cooperatively Suppress Necroptosis in Ischemic/Reperfused Hearts.

Authors:  Dongze Qin; Xiaohong Wang; Yutian Li; Liwang Yang; Ruitao Wang; Jiangtong Peng; Kobina Essandoh; Xingjiang Mu; Tianqing Peng; Qinghua Han; Kai-Jiang Yu; Guo-Chang Fan
Journal:  J Biol Chem       Date:  2016-08-08       Impact factor: 5.157

7.  Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of infarct size in 1,074 mice.

Authors:  Yiru Guo; Michael P Flaherty; Wen-Jian Wu; Wei Tan; Xiaoping Zhu; Qianhong Li; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2012-08-03       Impact factor: 17.165

8.  TNF-α, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.

Authors:  Eva S Kehmeier; Wolfgang Lepper; Martina Kropp; Christian Heiss; Ulrike Hendgen-Cotta; Jan Balzer; Mirja Neizel; Christian Meyer; Marc W Merx; Pablo E Verde; Christian Ohmann; Gerd Heusch; Malte Kelm; Tienush Rassaf
Journal:  Clin Res Cardiol       Date:  2012-05-06       Impact factor: 5.460

9.  Differential STAT3 signaling in the heart: Impact of concurrent signals and oxidative stress.

Authors:  Carlos Zgheib; Fouad A Zouein; Mazen Kurdi; George W Booz
Journal:  JAKSTAT       Date:  2012-04-01

10.  The COX-2/PGI2 receptor axis plays an obligatory role in mediating the cardioprotection conferred by the late phase of ischemic preconditioning.

Authors:  Yiru Guo; Deepali Nivas Tukaye; Wen-Jian Wu; Xiaoping Zhu; Michael Book; Wei Tan; Steven P Jones; Gregg Rokosh; Shuh Narumiya; Qianhong Li; Roberto Bolli
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.